ADPT

Adaptive Biotechnologies Stock Price

33.14
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
33.14

Low
30.41

52 Week Range

High
71.25

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Adaptive Biotechnologies Corporation ADPT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 33.14 20:00:00
Open Price Low Price High Price Close Price Prev Close
33.14
Bid Price Ask Price Spread News
33.25 33.50 0.25 - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 33.14 USD

Adaptive Biotechnologies Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 4.65B 140.31M 108.62M $ 98.38M $ - -1.10 -28.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 104.41k 4.10%

more financials information »

Adaptive Biotechnologies News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ADPT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week36.3037.5130.4134.551,291,389-3.16-8.71%
1 Month43.4144.9730.4138.78835,221-10.27-23.66%
3 Months62.9264.3330.4143.181,116,707-29.78-47.33%
6 Months50.9071.2530.4149.34971,284-17.76-34.89%
1 Year39.2371.2530.4146.14983,093-6.09-15.52%
3 Years39.0171.2515.2639.70931,005-5.87-15.05%
5 Years39.0171.2515.2639.70931,005-5.87-15.05%

Adaptive Biotechnologies Description

Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.


Your Recent History
NASDAQ
ADPT
Adaptive B..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.